Market Cap | ₹75Cr |
ROE | 2.12% |
P/E Ratio(TTM) | 2.70 |
EPS(TTM) | 2.46 |
P/B Ratio | 0.73 |
Dividend Yield | 0.00% |
Industry P/E | 39.66 |
Book Value | 9.12 |
Debt to Equity | 1.20 |
Face Value | 10 |
Parent Organisation | Welcure Drugs & Pharmaceuticals Limited |
Managing Director | Shri. Sudhir Chandra |
BSE Symbol | 524661 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.11 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.95 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 37.87 | ||
Wockhardt | NA (0.00%) | -188.18 |